J&J Submits Application to FDA for Ulcerative Colitis Treatment
Lead: Johnson & Johnson seeks FDA approval for Tremfya as a treatment for adults with ulcerative colitis, based on...
plaque psoriasis
Rani Therapeutics’ CT-P43 Trial Shows Promising Results
Rani Therapeutics Holdings has announced positive results from its Phase 1 clinical study of RT-111, a RaniPill capsule containing...
Arcutis Biotherapeutics Shares Surge on FDA Approval for Skin-Condition Treatment
Arcutis Biotherapeutics' stock surged 18% in after-hours trading after the FDA approved their treatment for seborrheic dermatitis, a skin...
Johnson & Johnson Faces Earnings Impact as Stelara Exclusivity Ends
Johnson & Johnson stock is trading lower after a Wells Fargo analyst expressed concerns about the company's future earnings...
Ventyx Biosciences Shares Plummet After VTX958 Setback
Ventyx Biosciences, a clinical-stage biopharmaceutical company, saw its shares plummet over 80% and hit a new all-time low after...
Ventyx Biosciences’ Stock Plunges After Failed Psoriasis Treatment Trial
Shares of Ventyx Biosciences Inc. plummeted 73.7% in premarket trading after the biopharmaceutical company announced it will no longer...
Ventyx Biosciences Terminates Trials for Inflammation Drug
Ventyx Biosciences, a San Diego-based company developing treatments for inflammatory diseases, will terminate two trials of its inflammation treatment...
Amgen Receives FDA Approval for Wezlana, a Treatment for Inflammatory Diseases
Amgen's treatment for multiple inflammatory diseases, Wezlana, has been approved by the FDA. Wezlana is a biosimilar to and...
Amgen Receives FDA Approval for Wezlana, a Treatment for Inflammatory Diseases
Amgen's treatment for multiple inflammatory diseases, Wezlana, has been approved by the FDA. Wezlana is a biosimilar to and...